Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics

SNOA Stock Summary

• SONOMA PHARMACEUTICALS INC's market capitalization of $4,881,709 is ahead of just 1.52% of US-listed equities.
• For SNOA, its debt to operating expenses ratio is greater than that reported by only 10.18% of US equities we're observing.
• With a year-over-year growth in debt of -59.84%, SONOMA PHARMACEUTICALS INC's debt growth rate surpasses only 4.01% of about US stocks.
• If you're looking for stocks that are quantitatively similar to SONOMA PHARMACEUTICALS INC, a group of peers worth examining would be IIIN, REX, FN, MPX, and SMID.
• Visit SNOA's SEC page to see the company's official filings. To visit the company's web site, go to www.sonomapharma.com.

SNOA Valuation Summary

• In comparison to the median Healthcare stock, SNOA's price/earnings ratio is 103.1% lower, now standing at -0.7.
• Over the past 196 months, SNOA's price/earnings ratio has gone up 3.4.

Below are key valuation metrics over time for SNOA.

SNOA Growth Metrics

Its 2 year net income to common stockholders growth rate is now at -72.64%.
• Its 3 year net income to common stockholders growth rate is now at 56.89%.
• Its year over year cash and equivalents growth rate is now at 75.26%.

SNOA's revenue has moved down $5,250,000 over the prior 52 months.

The table below shows SNOA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	12.556	-5.106	-6.787
2022-09-30	12.514	-5.084	-5.792
2022-06-30	12.927	-4.558	-4.875
2022-03-31	12.628	-4.248	-5.086
2021-12-31	12.487	-4.329	-5.802
2021-09-30	14.521	-3.257	-5.508

SNOA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SNOA has a Quality Grade of D, ranking ahead of 19.4% of graded US stocks.
• SNOA's asset turnover comes in at 1.011 -- ranking 24th of 682 Pharmaceutical Products stocks.
• AGLE, REGN, and NAVB are the stocks whose asset turnover ratios are most correlated with SNOA.

The table below shows SNOA's key quality metrics over time.